Current market trends and future projections for orphan drugs Novel strategies for formulating and delivering orphan drug therapies Recent case studies and real-world evidence in patient advocacy Tech-driven innovation and advances in rare disease therapy development Health equity and patient perspectives in orphan drug management Regulatory and policy shifts in the ecosystem of rare disease therapeutics Register Now: https://www.orphan-drug-summit.com/booking